Sodium oxybate

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Sodium oxybate or gamma-hydroxybutyrate (GHB) is sold under the brand name Xyrem is a restricted prescription drug licensed for the prevention of cataplexy (sudden, brief episodes of loss of muscle strength) and narcolepsy.[1][2]

Prescription sodium oxybate and Xyrem have significant differences from the illegal street drug also known as GHB.[3]

Side effects[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. "Sodium oxybate Uses, Side Effects & Warnings". Drugs.com. Retrieved Sep 25, 2020. 
  2. "Sodium Oxybate: MedlinePlus Drug Information". medlineplus.gov. Retrieved Sep 25, 2020. 
  3. Carter, Lawrence P.; Pardi, Daniel; Gorsline, Jane; Griffiths, Roland R. (Sep 1, 2009). "Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): differences in characteristics and misuse". Drug and alcohol dependence. 104 (1-2): 1–10. doi:10.1016/j.drugalcdep.2009.04.012. ISSN 0376-8716. PMC 2713368Freely accessible. PMID 19493637. 

adverse reaction - Any unintended or unwanted response to the treatment under investigation in a clinical trial.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.